Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners listed on this page.

Company Trademark Status Update Alerts are email updates of the latest trademarks' status change on company level. Click here to get the alert for FREE!

Hot News! On Monday, March 6, 2023, a U.S. federal trademark registration number 97824537 was filed for DENBYOS by Fresenius Kabi Deutschland GmbH with the description Pharmaceutical preparations for human use for the treatment of bone diseases and disorders; pharmaceutical preparations for human use for the treatment and prevention of osteoporosis.

Hot News! On Monday, March 6, 2023, a U.S. federal trademark registration number 97824564 was filed for KABDENZY by Fresenius Kabi Deutschland GmbH with the description Pharmaceutical preparations for human use for the treatment of bone diseases and disorders; pharmaceutical preparations for human use for the treatment and prevention of osteoporosis.

Hot News! On Monday, March 6, 2023, a U.S. federal trademark registration number 97824580 was filed for MOVLYTRA by Fresenius Kabi Deutschland GmbH with the description Pharmaceutical preparations for human use for the treatment of bone diseases and disorders; pharmaceutical preparations for human use for the treatment and prevention of osteoporosis.

Hot News! On Monday, March 6, 2023, a U.S. federal trademark registration number 97824600 was filed for CONEXXENCE by Fresenius Kabi Deutschland GmbH with the description Pharmaceutical preparations for human use for the treatment of bone diseases and disorders; pharmaceutical preparations for human use for the treatment and prevention of osteoporosis.

Hot News! On Tuesday, March 7, 2023, a U.S. federal trademark registration number 97826060 was filed for DENQUIVLA by Fresenius Kabi Deutschland GmbH with the description Pharmaceutical preparations for human use for the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for human use for the prevention of fractures; pharmaceutical preparations for human use for prevention of pain associated with oncological and metabolic diseases and disorders; pharmaceutical preparations for human use for surgery, namely, for prevention of skeletal-related events in patients with multiple myeloma and in patients with bone metastases from solid tumors; pharmaceutical preparations for human use for radiotherapy, namely, for prevention of skeletal-related events in patients with multiple myeloma and in patients with bone metastases from solid tumors; pharmaceutical preparations for human use for the treatment and prevention of bone metastases, solid tumors, osteolytic bone lesions of multiple myeloma, hypercalcemia of malignancy, giant cell tumor of bone.

Hot News! On Tuesday, March 7, 2023, a U.S. federal trademark registration number 97826064 was filed for OSSRINTA by Fresenius Kabi Deutschland GmbH with the description Pharmaceutical preparations for human use for the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for human use for the prevention of fractures; pharmaceutical preparations for human use for prevention of pain associated with oncological and metabolic diseases and disorders; pharmaceutical preparations for human use for surgery, namely, for prevention of skeletal-related events in patients with multiple myeloma and in patients with bone metastases from solid tumors; pharmaceutical preparations for human use for radiotherapy, namely, for prevention of skeletal-related events in patients with multiple myeloma and in patients with bone metastases from solid tumors; pharmaceutical preparations for human use for the treatment and prevention of bone metastases, solid tumors, osteolytic bone lesions of multiple myeloma, hypercalcemia of malignancy, giant cell tumor of bone.

Hot News! On Tuesday, March 7, 2023, a U.S. federal trademark registration number 97826069 was filed for ONCYFA by Fresenius Kabi Deutschland GmbH with the description Pharmaceutical preparations for human use for the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for human use for the prevention of fractures; pharmaceutical preparations for human use for prevention of pain associated with oncological and metabolic diseases and disorders; pharmaceutical preparations for human use for surgery, namely, for prevention of skeletal-related events in patients with multiple myeloma and in patients with bone metastases from solid tumors; pharmaceutical preparations for human use for radiotherapy, namely, for prevention of skeletal-related events in patients with multiple myeloma and in patients with bone metastases from solid tumors; pharmaceutical preparations for human use for the treatment and prevention of bone metastases, solid tumors, osteolytic bone lesions of multiple myeloma, hypercalcemia of malignancy, giant cell tumor of bone.

Hot News! On Tuesday, March 7, 2023, a U.S. federal trademark registration number 97826078 was filed for BOMYNTRA by Fresenius Kabi Deutschland GmbH with the description Pharmaceutical preparations for human use for the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for human use for the prevention of fractures; pharmaceutical preparations for human use for prevention of pain associated with oncological and metabolic diseases and disorders; pharmaceutical preparations for human use for surgery, namely, for prevention of skeletal-related events in patients with multiple myeloma and in patients with bone metastases from solid tumors; pharmaceutical preparations for human use for radiotherapy, namely, for prevention of skeletal-related events in patients with multiple myeloma and in patients with bone metastases from solid tumors; pharmaceutical preparations for human use for the treatment and prevention of bone metastases, solid tumors, osteolytic bone lesions of multiple myeloma, hypercalcemia of malignancy, giant cell tumor of bone.

Hot News! On Thursday, March 9, 2023, a U.S. federal trademark registration number 97830892 was filed for AUSIMZO by Fresenius Kabi Deutschland GmbH with the description Pharmaceutical preparations for treating immune and inflammatory diseases and disorders; pharmaceutical preparations for treating autoimmune diseases, illnesses and conditions.

Hot News! On Thursday, March 9, 2023, a U.S. federal trademark registration number 97831146 was filed for ALVYTU by Fresenius Kabi Deutschland GmbH with the description Pharmaceutical preparations for treating immune and inflammatory diseases and disorders; pharmaceutical preparations for treating autoimmune diseases, illnesses and conditions.

Hot News! On Thursday, March 9, 2023, a U.S. federal trademark registration number 97831170 was filed for OTULFI by Fresenius Kabi Deutschland GmbH with the description Pharmaceutical preparations for treating immune and inflammatory diseases and disorders; pharmaceutical preparations for treating autoimmune diseases, illnesses and conditions.